Verrica Pharmaceuticals (VRCA) Leases (2021 - 2025)
Verrica Pharmaceuticals has reported Leases over the past 5 years, most recently at $540000.0 for Q4 2025.
- Quarterly results put Leases at $540000.0 for Q4 2025, down 35.41% from a year ago — trailing twelve months through Dec 2025 was $540000.0 (down 35.41% YoY), and the annual figure for FY2025 was $540000.0, down 35.41%.
- Leases for Q4 2025 was $540000.0 at Verrica Pharmaceuticals, down from $616000.0 in the prior quarter.
- Over the last five years, Leases for VRCA hit a ceiling of $2.6 million in Q3 2024 and a floor of $540000.0 in Q4 2025.
- Median Leases over the past 5 years was $1.4 million (2023), compared with a mean of $1.3 million.
- Biggest five-year swings in Leases: skyrocketed 97.09% in 2024 and later tumbled 76.66% in 2025.
- Verrica Pharmaceuticals' Leases stood at $1.6 million in 2021, then decreased by 5.91% to $1.5 million in 2022, then dropped by 7.14% to $1.4 million in 2023, then tumbled by 40.5% to $836000.0 in 2024, then crashed by 35.41% to $540000.0 in 2025.
- The last three reported values for Leases were $540000.0 (Q4 2025), $616000.0 (Q3 2025), and $690000.0 (Q2 2025) per Business Quant data.